Cardiovascular endocrinology: Is ANGPTL3 the next PCSK9?

Nat Rev Endocrinol. 2017 Sep;13(9):503-504. doi: 10.1038/nrendo.2017.88. Epub 2017 Jul 14.

Authors

Kiran Musunuru¹, Sekar Kathiresan²

Affiliations

¹ Departments of Medicine and Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Blvd, 11-104 SCTR, Philadelphia, Pennsylvania 19104, USA.
² Center for Genomic Medicine, Massachusetts General Hospital, 185 Cambridge Street, CPZN 5.830, Boston, Massachusetts 02114, USA; and at the Program in Medical and Population Genetics, Broad Institute, 75 Ames Street, Cambridge, Massachusetts 02142, USA.

PMID: 28707678
DOI: 10.1038/nrendo.2017.88

No abstract available

Publication types

Comment

MeSH terms

Angiopoietin-Like Protein 3
Angiopoietin-like Proteins
Cardiovascular Diseases*
Cholesterol, LDL
Humans
Proprotein Convertase 9

Substances

ANGPTL3 protein, human
Angiopoietin-Like Protein 3
Angiopoietin-like Proteins
Cholesterol, LDL
PCSK9 protein, human
Proprotein Convertase 9